Behavioral
Happy Kids Pediatrics P.C.
Happy Kids Pediatrics P.C. was paid $50.43M by Medicaid between Jan 2018 and Dec 2024, across 128 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 30% of everything it billed.
33Billing provider infoHAPPY KIDS PEDIATRICS P.C.
TEMPE, AZ 85284
TEMPE, AZ 85284
33aNPI1821288606assigned 07/27/2007
33bProvider typeClinical Social Worker
28Total paid$50.43M
24GClaims1,314,026
24DCodes billed128
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Clinical Social Worker providers in Arizona
Rank by total paid#1 of 61
Median peer was paid$18K
This provider vs. median2,818×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 173,691 | $5.15M | |
| 2019 | 190,366 | $5.97M | |
| 2020 | 196,640 | $6.20M | |
| 2021 | 208,722 | $8.82M | |
| 2022 | 215,924 | $9.32M | |
| 2023 | 189,703 | $8.65M | |
| 2024incomplete | 138,980 | $6.32M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 30% | 280,777 | 247,823 | $15.35M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 11% | 77,637 | 71,735 | $5.66M |
| 95165 | Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials | 9.0% | 19,682 | 4,361 | $4.51M |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 7.1% | 44,935 | 44,612 | $3.60M |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 7.1% | 102,903 | 100,140 | $3.57M |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 5.8% | 33,033 | 32,624 | $2.91M |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 5.5% | 35,394 | 34,817 | $2.79M |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 4.1% | 27,756 | 27,189 | $2.04M |
| 95004 | Percutaneous tests with allergenic extracts, immediate type reaction | 2.3% | 4,771 | 4,560 | $1.14M |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1.9% | 22,106 | 19,255 | $961K |
| 90461 | 1.8% | 17,133 | 15,557 | $922K | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 1.7% | 35,779 | 34,840 | $839K |
116 more codes
| S9470 | Nutritional counseling, dietitian visit | 1.2% | 9,445 | $584K |
| 95117 | <1% | 52,796 | $500K | |
| 86328 | <1% | 11,715 | $479K | |
| 99383 | <1% | 3,695 | $338K | |
| 99381 | <1% | 3,941 | $333K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 21,025 | $305K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 9,184 | $291K |
| 90837 | Psychotherapy session, about an hour | <1% | 3,249 | $275K |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 3,605 | $251K |
| 92551 | <1% | 27,111 | $223K | |
| 99384 | <1% | 1,986 | $212K | |
| 96160 | <1% | 76,729 | $208K | |
| 99382 | <1% | 2,086 | $182K | |
| 95115 | <1% | 22,976 | $179K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 9,759 | $148K |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 1,445 | $139K |
| 97802 | <1% | 13,895 | $135K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 3,979 | $128K |
| 99173 | <1% | 59,086 | $121K | |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 976 | $101K |
| 0071A | <1% | 1,166 | $93K | |
| 99188 | <1% | 7,294 | $83K | |
| 90791 | Psychiatric diagnostic evaluation | <1% | 729 | $75K |
| 99493 | <1% | 844 | $73K | |
| 0072A | <1% | 863 | $70K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 4,146 | $59K |
| 94760 | <1% | 51,287 | $49K | |
| 96127 | <1% | 10,773 | $48K | |
| 99492 | <1% | 464 | $47K | |
| 99000 | <1% | 10,751 | $35K | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 409 | $35K |
| 0001A | <1% | 430 | $34K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 2,546 | $34K |
| 0002A | <1% | 398 | $33K | |
| 94664 | <1% | 1,873 | $23K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 2,332 | $23K |
| 99442 | <1% | 1,423 | $21K | |
| 94010 | <1% | 627 | $20K | |
| 90832 | Psychotherapy session, about 30 minutes | <1% | 446 | $18K |
| 36415 | Collection of venous blood by venipuncture | <1% | 5,438 | $15K |
| 81002 | <1% | 4,455 | $14K | |
| 90671 | <1% | 654 | $10K | |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 150 | $9K |
| 0003A | <1% | 121 | $9K | |
| 99460 | <1% | 132 | $8K | |
| 17110 | <1% | 90 | $8K | |
| S3620 | Newborn metabolic screening panel, includes test kit, postage and the laboratory tests specified by the state for inclusion in this panel (e.g., galactose; hemoglobin, electrophoresis; hydroxyprogesterone, 17-d; phenylalanine (pku); and thyroxine, total) | <1% | 163 | $7K |
| A7005 | Administration set, with small volume nonfiltered pneumatic nebulizer, non-disposable | <1% | 1,738 | $5K |
| 0011A | <1% | 190 | $5K | |
| 69209 | <1% | 250 | $5K | |
| 90834 | Psychotherapy session, about 45 minutes | <1% | 58 | $4K |
| 69210 | <1% | 69 | $3K | |
| 90651 | <1% | 5,656 | $3K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 249 | $3K |
| 99422 | <1% | 105 | $3K | |
| 99494 | <1% | 82 | $3K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 57 | $2K |
| 99385 | <1% | 25 | $2K | |
| 94761 | <1% | 1,764 | $2K | |
| 86769 | <1% | 5,273 | $2K | |
| 0012A | <1% | 78 | $2K | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 2,274 | $2K |
| 87807 | <1% | 87 | $1K | |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 12 | $1K |
| 90619 | <1% | 550 | $915.36 | |
| 90686 | <1% | 13,772 | $890.43 | |
| 90670 | <1% | 16,060 | $777.94 | |
| 36416 | <1% | 3,817 | $716.14 | |
| 94060 | <1% | 20 | $696.90 | |
| A7003 | Administration set, with small volume nonfiltered pneumatic nebulizer, disposable | <1% | 1,726 | $674.07 |
| 90633 | <1% | 8,875 | $564.63 | |
| T1016 | Case management, each 15 minutes | <1% | 29 | $483.33 |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 46 | $404.71 |
| 99462 | <1% | 12 | $319.57 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 1,407 | $291.78 |
| 90680 | <1% | 8,851 | $203.01 | |
| 90621 | <1% | 3,456 | $184.81 | |
| 99401 | <1% | 18 | $155.61 | |
| 90707 | <1% | 2,112 | $144.03 | |
| 90698 | <1% | 13,537 | $116.89 | |
| 81025 | <1% | 13 | $109.18 | |
| 90734 | <1% | 5,670 | $104.91 | |
| 90744 | <1% | 7,817 | $102.51 | |
| 96161 | <1% | 41 | $102.21 | |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 1,872 | $80.16 |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | <1% | 594 | $62.75 |
| 86318 | <1% | 365 | $54.45 | |
| G0444 | Annual depression screening, 5 to 15 minutes | <1% | 7,295 | $37.13 |
| 90715 | <1% | 2,518 | $34.88 | |
| A7004 | Small volume nonfiltered pneumatic nebulizer, disposable | <1% | 222 | $34.62 |
| 90716 | <1% | 1,961 | $15.67 | |
| 90700 | <1% | 1,537 | $6.62 | |
| 90696 | <1% | 2,811 | $5.31 | |
| 90649 | <1% | 2,559 | $2.63 | |
| 90648 | <1% | 1,020 | $2.47 | |
| 91307 | <1% | 221 | $1.44 | |
| 91300 | <1% | 276 | $0.76 | |
| 91301 | <1% | 44 | $0.06 | |
| 3016F | <1% | 6,715 | $0.01 | |
| 1000F | <1% | 6,644 | $0.01 | |
| G8431 | Screening for depression is documented as being positive and a follow-up plan is documented | 0% | 7,573 | $0.00 |
| 90710 | 0% | 3,000 | $0.00 | |
| 90685 | 0% | 404 | $0.00 | |
| 1159F | 0% | 1,465 | $0.00 | |
| E0445 | Oximeter device for measuring blood oxygen levels non-invasively | 0% | 447 | $0.00 |
| 3085F | 0% | 15 | $0.00 | |
| 3008F | 0% | 1,400 | $0.00 | |
| 90723 | 0% | 257 | $0.00 | |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | 0% | 5,233 | $0.00 |
| 97169 | 0% | 27 | $0.00 | |
| 86409 | 0% | 519 | $0.00 | |
| 90677 | 0% | 355 | $0.00 | |
| 90647 | 0% | 67 | $0.00 | |
| 87430 | 0% | 55 | $0.00 | |
| 90656 | 0% | 108 | $0.00 | |
| 1111F | 0% | 58 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialCARRAZCO, JOSE (OWNER)
| Provider | Location | Paid |
|---|---|---|
| Happy Kids Pediatrics P.C. | Mesa, AZ | $168K |
| Happy Kids Pediatrics P.C. | Mesa, AZ | $34K |
| Happy Kids Pediatrics P.C. | Glendale, AZ | $30K |
| Happy Kids Pediatrics P.C. | Phoenix, AZ | $22K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.